Moderately to Severely Active Crohn's Disease

DBCOND0093405Gastrointestinal Tract DisordersImmune System Diseases

Moderately to Severely Active Crohn's Disease is the indication for 4 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Moderately to Severely Active Crohns Disease
Classified under
Indicated drugs

What you can answer from here — as of October 23, 2026

4Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Moderately to Severely Active Crohn's Disease share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In